ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Anders Bresell |
| Institution: | AstraZeneca R&D |
| Department: | Clinical Information Managment |
| Country: | |
| Proposed Analysis: | Analyses and modeling to support study design of disease modifying studies Power calculations Enrichment strategies Define predictive biomarkers for fast progressors Define biomarkers for progression in general Define predictive markers of conversion from MCI to AD Imaging methodology evaluation |
| Additional Investigators | |
| Investigator's Name: | Niclas Sjögren |
| Proposed Analysis: | Statistical analysis, samples size estimates and data mining. |
| Investigator's Name: | Pär Karlsson |
| Proposed Analysis: | Disease modifier, statistics and modelling |
| Investigator's Name: | Ying Sun |
| Proposed Analysis: | Genetics, systems biology and translational analysis |